DE60036750D1 - Verfahren zur Abschätzung der Sensitivität für Osteoporose-Medikamente - Google Patents

Verfahren zur Abschätzung der Sensitivität für Osteoporose-Medikamente

Info

Publication number
DE60036750D1
DE60036750D1 DE60036750T DE60036750T DE60036750D1 DE 60036750 D1 DE60036750 D1 DE 60036750D1 DE 60036750 T DE60036750 T DE 60036750T DE 60036750 T DE60036750 T DE 60036750T DE 60036750 D1 DE60036750 D1 DE 60036750D1
Authority
DE
Germany
Prior art keywords
genetic polymorphisms
osteoporosis
receptor gene
gene
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60036750T
Other languages
English (en)
Other versions
DE60036750T2 (de
Inventor
Masataka Shiraki
Yasuyoshi Ouchi
Takayuki Hosoi
Nobutaka Kusaba
Toshiaki Baba
Hiroshi Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nipro Corp
Original Assignee
Nissho Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP16564299A external-priority patent/JP3684921B2/ja
Application filed by Nissho Corp filed Critical Nissho Corp
Application granted granted Critical
Publication of DE60036750D1 publication Critical patent/DE60036750D1/de
Publication of DE60036750T2 publication Critical patent/DE60036750T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DE60036750T 1999-05-18 2000-05-18 Verfahren zur Abschätzung der Sensitivität für Osteoporose-Medikamente Expired - Fee Related DE60036750T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP13665399 1999-05-18
JP13665399 1999-05-18
JP16564299 1999-06-11
JP16564299A JP3684921B2 (ja) 1999-06-11 1999-06-11 骨粗鬆症薬剤感受性予測方法

Publications (2)

Publication Number Publication Date
DE60036750D1 true DE60036750D1 (de) 2007-11-29
DE60036750T2 DE60036750T2 (de) 2008-08-28

Family

ID=26470156

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60036750T Expired - Fee Related DE60036750T2 (de) 1999-05-18 2000-05-18 Verfahren zur Abschätzung der Sensitivität für Osteoporose-Medikamente

Country Status (4)

Country Link
US (1) US6566064B1 (de)
EP (1) EP1054066B1 (de)
AT (1) ATE376066T1 (de)
DE (1) DE60036750T2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7319145B2 (en) * 2001-12-03 2008-01-15 Rima Rozen Methylenetetrahydrofolate reductase inhibitors and use thereof
KR100459493B1 (ko) * 2002-01-31 2004-12-03 김기수 골다공증의 발생 위험을 예측하는 방법 및 이를 이용한골다공증의 유전적 위험 인자에 대한 진단 키트
US8688385B2 (en) 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
JP2008500368A (ja) * 2004-05-27 2008-01-10 ミジェニックス コーポレイション 細胞保護のための２置換１７−イミノエストロゲン化合物
WO2006091092A1 (en) * 2005-02-28 2006-08-31 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Polymorphism analysis of the estrogen receptor and vitamin d receptor to predict therapy responsiveness in the treatment of osteoporosis
EP3703058A1 (de) * 2005-11-29 2020-09-02 Children's Hospital Medical Center Verfahren zur auswahl eines medikamentes für einen patienten
GB0614620D0 (en) * 2006-07-24 2006-08-30 Genomica Sau Assay for diagnosing a predisposition to pathological bone conditions and anticipating response to treatment
JP2013504571A (ja) * 2009-09-14 2013-02-07 ネステク ソシエテ アノニム 外因性ビタミンｋ２を含む栄養組成物
US10445846B2 (en) 2011-04-14 2019-10-15 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
US9626650B2 (en) 2011-04-14 2017-04-18 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
CN108451929B (zh) * 2017-02-21 2021-04-16 上海交通大学医学院 一种包载固相内核的重组脂蛋白及其制备和应用

Also Published As

Publication number Publication date
US6566064B1 (en) 2003-05-20
DE60036750T2 (de) 2008-08-28
ATE376066T1 (de) 2007-11-15
EP1054066B1 (de) 2007-10-17
EP1054066A2 (de) 2000-11-22
EP1054066A3 (de) 2004-02-25

Similar Documents

Publication Publication Date Title
CN105112502B (zh) 用于检测与糖尿病相关的snp位点组合的成套引物及其应用
CN107190064B (zh) 检测22个位点耳聋基因多态性的SNaPshot试剂盒
DE60036750D1 (de) Verfahren zur Abschätzung der Sensitivität für Osteoporose-Medikamente
US20030143572A1 (en) Molecular diagnostic and computerized decision support system for selecting the optimum treatment for human cancer
CN110684838A (zh) 一种肥厚型心肌病基因检测试剂盒
CN106319040A (zh) 一种检测人cyp2c19基因分型的试剂盒及检测方法
JP5216982B2 (ja) 禁煙支援治療に有用な遺伝子多型
CN108048565A (zh) 一种检测ApoE基因多态性的引物及其检测方法和应用
KR101712463B1 (ko) 혈압강하제 및 동맥 경화용제 대사효소 관련 유전자 snp 지노타이핑 시약, 이를 포함하는 키트 및 유전자형 분석방법
CN110656112B (zh) 一种Liddle综合征基因检测试剂盒
DE60014887D1 (de) Analyseverfahren zur feststellung der prädisposition enes patienten auf mindestens eine erkrankung sowie geeignete amplifizierung für ein solches verfahren
JP6596724B1 (ja) 白髪の遺伝的素因の判定方法
CN105274197B (zh) 用于生物样本核酸检测的质控方法及试剂盒
Chiou et al. Detection of common sequence variations of familial hypercholesterolemia in Taiwan using DNA mass spectrometry
Jung et al. Development of HLA-B* 57: 01 genotyping real-time PCR with optimized hydrolysis probe design
CN114729395A (zh) 检查脑肿瘤的方法
RU2607031C1 (ru) Способ выявления кандидатных генов для проведения популяционных исследований генетического полиморфизма у детей, проживающих в условиях стронциевой геохимической провинции
CN107828889B (zh) 一种用于hla-drb1*03基因定性检测的pcr扩增引物及试剂盒
RU2006101561A (ru) Способы обнаружения болезни альцгеймера
KR101712460B1 (ko) 항바이러스제 대사효소와 수용체 관련 유전자 snp 지노타이핑 시약, 이를 포함하는 키트 및 유전자형 분석방법
JP5396009B2 (ja) 骨粗鬆症感受性遺伝子、及び骨粗鬆症罹患リスクの測定方法
KR100790226B1 (ko) 독성 간염 유발 감수성을 검출하는 방법
Wang et al. High throughput analysis of tandem repeat contraction associated with Facioscapulohumeral Muscular Dystrophy (FSHD) by optical mapping
KR101998204B1 (ko) 전립선암 진단을 위한 디지털 pcr용 프라이머 세트 및 이의 용도
JP5809205B2 (ja) 骨粗鬆症感受性遺伝子、及び骨粗鬆症罹患リスクの測定方法

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: NIPRO CORP., OSAKA, JP

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee